{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T06:27:22Z","timestamp":1749018442110},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2023.12683","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T16:05:13Z","timestamp":1683734713000},"page":"e2312683","source":"Crossref","is-referenced-by-count":5,"title":["Identifying Barriers to OUD Treatment Linkage From the Emergency Department to the Community"],"prefix":"10.1001","volume":"6","author":[{"given":"Susan L.","family":"Calcaterra","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of General Internal Medicine and Division of Hospital Medicine, University of Colorado, Aurora"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hospital Medicine, University of California San Francisco and San Francisco General Hospital, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honora","family":"Englander","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Addiction Medicine and Division of Hospital Medicine, Oregon Health and Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"issue":"16","key":"zic230066r2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial.","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"zic230066r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine.","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zic230066r4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"zic230066r5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.12718","article-title":"Perspectives of clinicians and staff at community-based opioid use disorder treatment settings on linkages with emergency department\u2013initiated buprenorphine programs.","volume":"6","author":"Sue","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zic230066r6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13012-019-0891-5","article-title":"Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).","volume":"14","author":"D\u2019Onofrio","year":"2019","journal-title":"Implement Sci"},{"issue":"6","key":"zic230066r8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/tmj.2021.0308","article-title":"Utilization of telehealth solutions for patients with opioid use disorder using buprenorphine: a scoping review.","volume":"28","author":"Guillen","year":"2022","journal-title":"Telemed J E Health"},{"issue":"5","key":"zic230066r9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/10826084.2023.2177972","article-title":"Scope of, motivations for, and outcomes associated with buprenorphine diversion in the United States: a scoping review.","volume":"58","author":"Rubel","year":"2023","journal-title":"Subst Use Misuse"},{"key":"zic230066r1","unstructured":"US Centers for Disease Control and Prevention. Drug overdose deaths in the United States, 2001\u20132021. Updated December 21, 2022. Accessed January 12, 2023. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db457.htm#section_1"},{"key":"zic230066r7","unstructured":"Substance Abuse and Mental Health Services Administration. FAQs: Provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency. April 2020. Accessed April 12, 2023. https:\/\/www.samhsa.gov\/sites\/default\/files\/faqs-for-oud-prescribing-and-dispensing.pdf"},{"key":"zic230066r10","unstructured":"Mainstreaming Addiction Treatment Act of 2021. Congress.gov. Accessed April 12, 2023. https:\/\/www.congress.gov\/bill\/117th-congress\/house-bill\/1384?q=%7B%22search%22%3A%5B%22Mainstreaming+Addiction+Treatment+Act+of+2021%22%5D%7D&s=1&r=2"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2804679\/calcaterra_2023_ic_230066_1683052063.36959.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T14:57:15Z","timestamp":1702393035000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2804679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.12683","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]}}}